New Key Statistics Module, Z-Score and F-Score
NAS:RPRX Key Ratios
Market Cap $ M | 11,285.26 |
Enterprise Value $ M | 20,441.37 |
P/E(ttm) | 9.96 |
PE Ratio without NRI | 12.97 |
Forward PE Ratio | 5.83 |
Price/Book | 1.65 |
Price/Sales | 6.68 |
Price/Free Cash Flow | 5.41 |
Price/Owner Earnings | -- |
Payout Ratio % | 0.42 |
Revenue (TTM) $ M | 2,266.00 |
EPS (TTM) $ | 2.55 |
Beneish M-Score | -3.32 |
10-y EBITDA Growth Rate % | -- |
5-y EBITDA Growth Rate % | -23.00 |
y-y EBITDA Growth Rate % | 454.60 |
EV-to-EBIT | 10.64 |
EV-to-EBITDA | 10.64 |
PEG | -- |
Shares Outstanding M | 444.30 |
Net Margin (%) | 50.53 |
Operating Margin % | 68.13 |
Pre-tax Margin (%) | 75.64 |
Quick Ratio | 1.54 |
Current Ratio | 1.54 |
ROA % (ttm) | 6.81 |
ROE % (ttm) | 17.61 |
ROIC % (ttm) | 10.12 |
Dividend Yield % | 3.27 |
Altman Z-Score | 1.60 |
RPRX Number of Guru Trades
RPRX Volume of Guru Trades
Gurus Latest Trades with NAS:RPRX
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
NAS:RPRX is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Royalty Pharma PLC Insider Transactions
No Available Data
News about NAS:RPRX
Total 0- 1